Atlas Trials

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Clinical trial NCT06709040 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT06709040
Sponsor
Novo Nordisk A/S
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Growth Hormone DeficiencyNeoplasmsDiabetes Mellitus Type 2
Start date
2024-12-13
Primary completion
2034-04-14
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.